Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20156006 | 0.91 | ALDH1A1 (0.39) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL20156026 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL24886301 | 0.79 | ALDH1A1 (0.44) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL20156005 | 0.74 | ALDH1A1 (0.33) | ALDH1A1CYP2D6SMN1; SMN2GLO1 | |
| SCHEMBL14838887 | 0.74 | ALDH1A1 (0.42) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL20156348 | 0.71 | CYP2D6 (0.40) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL23953799 | 0.69 | NPSR1 (0.43) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL3956082 | 0.68 | ALDH1A1 (0.43) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL14346035 | 0.68 | NPSR1 (0.42) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT | |
| SCHEMBL20156244 | 0.68 | CYP2D6 (0.44) | ALDH1A1CYP2D6SMN1; SMN2GLO1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538527-B1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-10-13 | — | — | EP | disclosed |